Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Post by bwlingon Sep 05, 2020 8:26pm
276 Views
Post# 31516093

MIR long term share price projection of C$3.00

MIR long term share price projection of C$3.00

Hang on to your shares and wait for the prize!

Message below posted by EcoIntel on another board.
 

https://www.wallstreet-online.de/nachricht/12902844-medmira-vorwaerts-lang-wars-ruhig-medmira-artikel-globe-newswire-facht-spekulation-an


Sensitivity and Specification of REVEALCOVID-19™ Total Antibody Test

According to recent scientific studies, antibodies to the SARS-CoV-2 virus can be detected 1-3 weeks after the onset of symptoms. To demonstrate the sensitivity and specification of MedMira's REVEALCOVID-19™ Total Antibody Test, blood samples were tested for positive and negative antibodies of the SARS-CoV-2 virus test and the causative agent of COVID-19 together. Positive blood samples from individuals who were found to be infected were collected and analyzed together with negative blood samples that were genotyped before the pandemic. The results are very interesting: Sensitivity: over 7 days after symptoms 99.1% The FDA has a minimum threshold of 90% ! Accuracy: 98.9% The FDA requires 95% !

The REVEALCOVID-19™ antibody test was examined for false results in connection with HIV positive samples, i.e. whether there is a cross-reaction of tests. For this purpose, a total of 284 negative samples were taken of which 50 were HIV positive. NO cross-reaction could be detected!

This is a very important step in the right direction and for the FDA a prerequisite for approval. MedMira already produces the tests and can distribute them under an FDA emergency approval in the USA while waiting for the main approval. Since May 21, 2020, the test can be sold in all other countries that have a CE mark approval. The chart is still exciting and shows considerable potential.
 
The downward trend has broken upward. The current correction led exactly to the lower limit and should be almost eliminated with yesterday's rise. The longer term target price is calculated at 3 CAD which seems ambitious. I believe rather in the old high points with 1,50-1,75 CAD. With FDA approval, these should be reached very quickly. The stock is speculative and has not been noticed by active communication. However, the turnover and the high volatility shows that the company is on the radar of many traders and algotraders. So it's all about when the news is positive and vice versa. This has been demonstrated this year with an increase from 6 cents to a peak of 89 cents! With the FDA approval a fireworks display could start again. I am curious about it. This is not an investment advice and no invitation to buy or sell stocks. Everybody has to know for himself what kind of risk he can take and has to be confident. Everyone is responsible for himself. Attention conflict of interest: I own the shares discussed in this article or are they included in the SRC Mining Special Situations Certificate. Good luck and best wishes from Switzerland. Your Jochen Staiger
 
Translated with www.DeepL.com/Translator (free version)

Bullboard Posts